<h3>关键洞察</h3>
<ul>
<li>内部人士似乎对医思健康的增长有着切身利益，因为他们拥有相当大的股份</li>
<li>61% 的公司股份由单一股东（邓志辉）持有</li>
<li>结合所有权研究和过去的业绩数据，可以帮助更好地理解股票中的机会</li>
</ul>
<p>人工智能即将改变医疗保健。这 20 只股票正在从早期诊断到药物发现等各个方面进行探索。最棒的是——它们的市值都在 100 亿美元以下——现在仍然有机会提前介入。</p>
<p>如果你想知道谁真正控制了医思健康（HKG:2138），那么你需要查看其股东名册的构成。我们可以看到，个人内部人士在公司中拥有 62% 的股份。换句话说，这个群体将从他们对公司的投资中获得最多的收益（或承受最多的损失）。</p>
<p>在上周股价下跌 15% 之后，内部人士遭受了最大的损失。</p>
<p>让我们深入了解医思健康每种类型的所有者，从下面的图表开始。</p>
<p>查看我们对医思健康的最新分析</p>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/325403569-ownership-breakdown-1-dark-2/1756358337859?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/325403569-ownership-breakdown-1-dark-2/1756358337859"/></p>
<p>SEHK:2138 所有权分布 2025 年 8 月 28 日</p>
<h2>机构所有权对医思健康的启示是什么？</h2>
<p>机构通常在向自己的投资者报告时会以基准进行衡量，因此一旦某只股票被纳入主要指数，他们往往会对该股票更加热衷。我们预计大多数公司在股东名册上会有一些机构，特别是如果它们正在增长的话。</p>
<p>医思健康的股东名册上已经有机构投资者。实际上，他们在公司中拥有相当可观的股份。这可以表明该公司在投资界具有一定的信誉。然而，最好对依赖机构投资者所带来的所谓验证保持警惕。他们有时也会犯错。当多家机构持有一只股票时，总是存在它们处于 “拥挤交易” 的风险。当这种交易出现问题时，多个参与方可能会争相快速出售股票。在没有增长历史的公司中，这种风险更高。你可以在下面看到医思健康的历史收益和收入，但请记住，事情总是有更多的故事。</p>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/325403569-earnings-and-revenue-growth-1-dark-2/1756358338915?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/325403569-earnings-and-revenue-growth-1-dark-2/1756358338915"/></p>
<p>SEHK:2138 收益和收入增长 2025 年 8 月 28 日</p>
<p>医思健康并不被对冲基金持有。因为行动胜于言辞，我们认为内部人士在公司中拥有显著股份是一个好迹象。在医思健康的案例中，其首席执行官邓志辉是最大股东，持有 61% 的流通股份。高盛集团、投资银行和证券投资是第二大股东，持有 4.8% 的普通股，而 MCP 新兴市场有限合伙公司持有约 1.7% 的公司股份。</p>
<p>研究机构所有权是评估和筛选股票预期表现的好方法。通过研究分析师的情绪也可以实现同样的目的。我们的信息表明，该股票没有分析师覆盖，因此可能知名度不高。</p>
<h2>医思健康的内部人士所有权</h2>
<p>内部人士的定义在不同国家之间可能略有不同，但董事会成员始终算在内。管理层最终对董事会负责。然而，管理者作为执行董事会成员并不罕见，特别是如果他们是创始人或首席执行官。</p>
<p>我通常认为内部人士拥有股份是件好事。然而，在某些情况下，这使得其他股东更难让董事会对决策负责。</p>
<p>我们的信息表明，内部人士拥有超过一半的医思健康股份。这使他们有效控制了公司。这意味着他们在这家市值为 9.84 亿港元的公司中拥有价值 6.09 亿港元的股份。这是相当有意义的。看到这种投资水平是件好事。你可以在这里查看这些内部人士最近是否有买入。</p>
<h2>公众一般所有权</h2>
<p>公众持有 29% 的股份，主要由个人投资者组成，对医思健康有一定的影响力。虽然这种规模的所有权可能不足以影响政策决策，但他们仍然可以对公司政策产生集体影响。</p>
<h2>下一步：</h2>
<p>我发现查看谁真正拥有一家公司非常有趣。但要真正获得洞察，我们还需要考虑其他信息。例如：我们发现 <strong>医思健康有 2 个警告信号</strong> 你应该注意，其中一个令人担忧。</p>
<p>如果你更愿意查看另一家公司——一家可能财务状况更优越的公司——那么不要错过这份 <strong>免费</strong> 的有趣公司名单，背后有强大的财务数据支持。</p>
<p>注意：本文中的数据是根据过去 12 个月的数据计算得出的，指的是财务报表日期所在月份的最后一天结束的 12 个月期间。这可能与全年年报数据不一致。</p>

医思健康

<p>医思健康的首席执行官邓志辉在最近股价回调后，其持股价值下降了 15%。他持有公司 61% 的股份，显示出显著的内部持股，这可能影响公司的决策。机构投资者拥有相当的股份，但没有分析师覆盖，表明市场认知有限。公众持有 29% 的股份，对公司政策有一定影响。尽管内部持股是一个积极的信号，但仍存在一些担忧，包括公司被识别出的两个警示信号</p>

<h3>Key Insights</h3>
<div class="lb-trans"><h3>关键洞察</h3>
</div><ul>
<li>Insiders appear to have a vested interest in EC Healthcare's growth, as seen by their sizeable ownership</li>
<li>61% of the company is held by a single shareholder (Chi Fai Tang)</li>
<li>Ownership research, combined with past performance data can help provide a good understanding of opportunities in a stock</li>
</ul>
<div class="lb-trans"><ul>
<li>内部人士似乎对医思健康的增长有着切身利益，因为他们拥有相当大的股份</li>
<li>61% 的公司股份由单一股东（邓志辉）持有</li>
<li>结合所有权研究和过去的业绩数据，可以帮助更好地理解股票中的机会</li>
</ul>
</div><p>AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.</p>
<div class="lb-trans"><p>人工智能即将改变医疗保健。这 20 只股票正在从早期诊断到药物发现等各个方面进行探索。最棒的是——它们的市值都在 100 亿美元以下——现在仍然有机会提前介入。</p>
</div><p>If you want to know who really controls EC Healthcare (HKG:2138), then you'll have to look at the makeup of its share registry. We can see that individual insiders own the lion's share in the company with 62% ownership. In other words, the group stands to gain the most (or lose the most) from their investment into the company.</p>
<div class="lb-trans"><p>如果你想知道谁真正控制了医思健康（HKG:2138），那么你需要查看其股东名册的构成。我们可以看到，个人内部人士在公司中拥有 62% 的股份。换句话说，这个群体将从他们对公司的投资中获得最多的收益（或承受最多的损失）。</p>
</div><p>And following last week's 15% decline in share price, insiders suffered the most losses.</p>
<div class="lb-trans"><p>在上周股价下跌 15% 之后，内部人士遭受了最大的损失。</p>
</div><p>Let's delve deeper into each type of owner of EC Healthcare, beginning with the chart below.</p>
<div class="lb-trans"><p>让我们深入了解医思健康每种类型的所有者，从下面的图表开始。</p>
</div><p>See our latest analysis for EC Healthcare</p>
<div class="lb-trans"><p>查看我们对医思健康的最新分析</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/325403569-ownership-breakdown-1-dark-2/1756358337859" alt="" original-src="https://images.simplywall.st/asset/chart/325403569-ownership-breakdown-1-dark-2/1756358337859"/></p>
<p>SEHK:2138 Ownership Breakdown August 28th 2025</p>
<div class="lb-trans"><p>SEHK:2138 所有权分布 2025 年 8 月 28 日</p>
</div><h2>What Does The Institutional Ownership Tell Us About EC Healthcare?</h2>
<div class="lb-trans"><h2>机构所有权对医思健康的启示是什么？</h2>
</div><p>Institutions typically measure themselves against a benchmark when reporting to their own investors, so they often become more enthusiastic about a stock once it's included in a major index. We would expect most companies to have some institutions on the register, especially if they are growing.</p>
<div class="lb-trans"><p>机构通常在向自己的投资者报告时会以基准进行衡量，因此一旦某只股票被纳入主要指数，他们往往会对该股票更加热衷。我们预计大多数公司在股东名册上会有一些机构，特别是如果它们正在增长的话。</p>
</div><p>EC Healthcare already has institutions on the share registry. Indeed, they own a respectable stake in the company. This can indicate that the company has a certain degree of credibility in the investment community. However, it is best to be wary of relying on the supposed validation that comes with institutional investors. They too, get it wrong sometimes. When multiple institutions own a stock, there's always a risk that they are in a 'crowded trade'. When such a trade goes wrong, multiple parties may compete to sell stock fast. This risk is higher in a company without a history of growth. You can see EC Healthcare's historic earnings and revenue below, but keep in mind there's always more to the story.</p>
<div class="lb-trans"><p>医思健康的股东名册上已经有机构投资者。实际上，他们在公司中拥有相当可观的股份。这可以表明该公司在投资界具有一定的信誉。然而，最好对依赖机构投资者所带来的所谓验证保持警惕。他们有时也会犯错。当多家机构持有一只股票时，总是存在它们处于 “拥挤交易” 的风险。当这种交易出现问题时，多个参与方可能会争相快速出售股票。在没有增长历史的公司中，这种风险更高。你可以在下面看到医思健康的历史收益和收入，但请记住，事情总是有更多的故事。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/325403569-earnings-and-revenue-growth-1-dark-2/1756358338915" alt="" original-src="https://images.simplywall.st/asset/chart/325403569-earnings-and-revenue-growth-1-dark-2/1756358338915"/></p>
<p>SEHK:2138 Earnings and Revenue Growth August 28th 2025</p>
<div class="lb-trans"><p>SEHK:2138 收益和收入增长 2025 年 8 月 28 日</p>
</div><p>EC Healthcare is not owned by hedge funds. Because actions speak louder than words, we consider it a good sign when insiders own a significant stake in a company. In EC Healthcare's case, its Top Key Executive, Chi Fai Tang, is the largest shareholder, holding 61% of shares outstanding. Goldman Sachs Group, Investment Banking and Securities Investments is the second largest shareholder owning 4.8% of common stock, and MCP Emerging Markets LLP holds about 1.7% of the company stock.</p>
<div class="lb-trans"><p>医思健康并不被对冲基金持有。因为行动胜于言辞，我们认为内部人士在公司中拥有显著股份是一个好迹象。在医思健康的案例中，其首席执行官邓志辉是最大股东，持有 61% 的流通股份。高盛集团、投资银行和证券投资是第二大股东，持有 4.8% 的普通股，而 MCP 新兴市场有限合伙公司持有约 1.7% 的公司股份。</p>
</div><p>Researching institutional ownership is a good way to gauge and filter a stock's expected performance. The same can be achieved by studying analyst sentiments. Our information suggests that there isn't any analyst coverage of the stock, so it is probably little known.</p>
<div class="lb-trans"><p>研究机构所有权是评估和筛选股票预期表现的好方法。通过研究分析师的情绪也可以实现同样的目的。我们的信息表明，该股票没有分析师覆盖，因此可能知名度不高。</p>
</div><h2>Insider Ownership Of EC Healthcare</h2>
<div class="lb-trans"><h2>医思健康的内部人士所有权</h2>
</div><p>The definition of an insider can differ slightly between different countries, but members of the board of directors always count. Management ultimately answers to the board. However, it is not uncommon for managers to be executive board members, especially if they are a founder or the CEO.</p>
<div class="lb-trans"><p>内部人士的定义在不同国家之间可能略有不同，但董事会成员始终算在内。管理层最终对董事会负责。然而，管理者作为执行董事会成员并不罕见，特别是如果他们是创始人或首席执行官。</p>
</div><p>I generally consider insider ownership to be a good thing. However, on some occasions it makes it more difficult for other shareholders to hold the board accountable for decisions.</p>
<div class="lb-trans"><p>我通常认为内部人士拥有股份是件好事。然而，在某些情况下，这使得其他股东更难让董事会对决策负责。</p>
</div><p>Our information suggests that insiders own more than half of EC Healthcare. This gives them effective control of the company. That means they own HK$609m worth of shares in the HK$984m company. That's quite meaningful. It is good to see this level of investment. You can check here to see if those insiders have been buying recently.</p>
<div class="lb-trans"><p>我们的信息表明，内部人士拥有超过一半的医思健康股份。这使他们有效控制了公司。这意味着他们在这家市值为 9.84 亿港元的公司中拥有价值 6.09 亿港元的股份。这是相当有意义的。看到这种投资水平是件好事。你可以在这里查看这些内部人士最近是否有买入。</p>
</div><h2>General Public Ownership</h2>
<div class="lb-trans"><h2>公众一般所有权</h2>
</div><p>With a 29% ownership, the general public, mostly comprising of individual investors, have some degree of sway over EC Healthcare. While this size of ownership may not be enough to sway a policy decision in their favour, they can still make a collective impact on company policies.</p>
<div class="lb-trans"><p>公众持有 29% 的股份，主要由个人投资者组成，对医思健康有一定的影响力。虽然这种规模的所有权可能不足以影响政策决策，但他们仍然可以对公司政策产生集体影响。</p>
</div><h2>Next Steps:</h2>
<div class="lb-trans"><h2>下一步：</h2>
</div><p>I find it very interesting to look at who exactly owns a company. But to truly gain insight, we need to consider other information, too. Case in point: We've spotted <strong>2 warning signs for EC Healthcare</strong> you should be aware of, and 1 of them is concerning.</p>
<div class="lb-trans"><p>我发现查看谁真正拥有一家公司非常有趣。但要真正获得洞察，我们还需要考虑其他信息。例如：我们发现 <strong>医思健康有 2 个警告信号</strong> 你应该注意，其中一个令人担忧。</p>
</div><p>If you would prefer check out another company -- one with potentially superior financials -- then do not miss this <strong>free</strong> list of interesting companies, backed by strong financial data.</p>
<div class="lb-trans"><p>如果你更愿意查看另一家公司——一家可能财务状况更优越的公司——那么不要错过这份 <strong>免费</strong> 的有趣公司名单，背后有强大的财务数据支持。</p>
</div><p>NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.</p>
<div class="lb-trans"><p>注意：本文中的数据是根据过去 12 个月的数据计算得出的，指的是财务报表日期所在月份的最后一天结束的 12 个月期间。这可能与全年年报数据不一致。</p>
</div>

医思健康（HKG:2138）高管邓志辉的持股因近期股价回调而价值减少了 15%